FERRI, GIAN LUCA
 Distribuzione geografica
Continente #
EU - Europa 188.727
NA - Nord America 11.533
AS - Asia 4.654
SA - Sud America 621
Continente sconosciuto - Info sul continente non disponibili 274
AF - Africa 82
OC - Oceania 28
Totale 205.919
Nazione #
IT - Italia 183.854
US - Stati Uniti d'America 11.396
NL - Olanda 1.902
CN - Cina 1.792
SG - Singapore 1.768
UA - Ucraina 868
SE - Svezia 692
BR - Brasile 487
VN - Vietnam 378
DE - Germania 367
FI - Finlandia 342
GB - Regno Unito 266
FR - Francia 256
HK - Hong Kong 197
KR - Corea 103
IN - India 87
CA - Canada 78
BD - Bangladesh 64
AR - Argentina 44
RU - Federazione Russa 44
JP - Giappone 43
IQ - Iraq 31
TR - Turchia 31
PL - Polonia 28
EC - Ecuador 27
MX - Messico 27
ZA - Sudafrica 27
ES - Italia 25
PK - Pakistan 25
AU - Australia 24
BE - Belgio 16
UZ - Uzbekistan 15
CL - Cile 14
CO - Colombia 14
ID - Indonesia 14
MA - Marocco 13
VE - Venezuela 13
PH - Filippine 12
IR - Iran 11
SA - Arabia Saudita 11
CZ - Repubblica Ceca 10
EU - Europa 10
JO - Giordania 10
MU - Mauritius 10
MY - Malesia 10
AT - Austria 9
IE - Irlanda 8
CH - Svizzera 7
EG - Egitto 7
JM - Giamaica 7
PY - Paraguay 7
TN - Tunisia 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
AZ - Azerbaigian 6
CR - Costa Rica 6
TH - Thailandia 6
KE - Kenya 5
RO - Romania 5
BB - Barbados 4
DZ - Algeria 4
KZ - Kazakistan 4
OM - Oman 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
GY - Guiana 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LT - Lituania 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PE - Perù 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
TW - Taiwan 3
BH - Bahrain 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HN - Honduras 2
KH - Cambogia 2
MD - Moldavia 2
QA - Qatar 2
RS - Serbia 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
IS - Islanda 1
KG - Kirghizistan 1
KI - Kiribati 1
KY - Cayman, isole 1
LB - Libano 1
LV - Lettonia 1
Totale 205.642
Città #
Cagliari 180.457
Uta 2.740
Amsterdam 1.883
Fairfield 1.030
Singapore 931
Woodbridge 865
Ashburn 841
Chandler 784
Houston 681
San Jose 622
Ann Arbor 563
Wilmington 513
Boardman 494
Jacksonville 462
Nyköping 430
Seattle 428
Dallas 415
Cambridge 356
Beijing 287
Los Angeles 257
Helsinki 202
Hong Kong 181
Council Bluffs 168
Hefei 165
Dearborn 158
Santa Clara 155
Nanjing 144
Shanghai 141
Boston 139
Buffalo 139
The Dalles 132
New York 129
Lauterbourg 128
Ho Chi Minh City 116
Seoul 101
Hanoi 77
Milan 70
Dong Ket 58
San Diego 58
Guangzhou 57
Chicago 52
Munich 49
Jiaxing 47
Tianjin 47
Verona 46
São Paulo 45
Nanchang 42
Shenyang 41
Phoenix 40
Rome 39
Changsha 36
Hebei 36
Tokyo 36
Redwood City 34
Toronto 30
Columbus 29
Norwalk 28
Orem 28
Orange 26
Brooklyn 24
Rio de Janeiro 23
Atlanta 22
Da Nang 22
Frankfurt am Main 21
Mountain View 21
San Mateo 21
Sydney 21
Warsaw 21
Denver 20
Hangzhou 20
Jinan 20
London 20
Redondo Beach 20
Belo Horizonte 19
Auburn Hills 18
Chennai 18
Johannesburg 18
Nuremberg 18
San Francisco 18
Zhengzhou 18
Montreal 16
Saint Petersburg 15
Washington 14
Falls Church 13
Ningbo 12
Tashkent 12
Baghdad 11
Curitiba 11
Kunming 11
Can Tho 10
Düsseldorf 10
Manchester 10
Pisa 10
Pune 10
Renton 10
Sassari 10
Stockholm 10
Amman 9
Brussels 9
Haiphong 9
Totale 198.933
Nome #
VGF peptide profiles in Type 2 diabetic patients' plasma and in obese mice 4.798
VGF protein and its C-terminal derived peptides in amyotrophic lateral sclerosis: Human and animal model studies 4.789
Photoperiod Regulates vgf-Derived Peptide Processing in Siberian Hamsters 4.371
Involvement of nigral oxytocin in locomotor activity: a behavioral, immunohistochemical and lesion study in male rats 4.092
Profiles of VGF peptides in the rat brain and their modulations after Phencyclidine treatment 4.084
Targeting Substantia Nigra through Oxytocin Receptors. 3.875
VGF: an inducible gene product, precursor of a diverse array of neuro-endocrine peptides and tissue-specific disease biomarkers. 3.866
VGF and Type II Diabetes: Decrease of VGF fragment levels in adipose tissues of diet-induced obese mice 3.861
Selective expression of TLQP-21 and other VGF peptides in gastric neuroendocrine cells and modulation by feeding 3.859
Parkinson’s disease: changes in TLQP and related peptide/s in 6-OHDA treated rat and in human plasma 3.758
VGF-peptides in the Siberian hamster 3.692
Hypothalamic over-expression of VGF in the Siberian hamster increases energy expenditure and reduces body weight gain 3.660
VGF peptides: differential expression in motor neurons, and possible changes in Amyotrophic Lateral Sclerosis (ALS). 3.644
Distribution of VGF peptides in the human cortex and their selective changes in Parkinson's and Alzheimer's diseases 3.609
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.517
Selective expression of vgf-derived peptides in gastric endocrine cells: differential modulation of TLQP-peptides by feeding 3.435
VGF changes during the estrous cycle: a novel endocrine role for TLQP peptides? 3.367
VGF peptides in hypothalamus-pituitary axis in the rat estrous cycle 3.210
Reduction of Total Brain and Cerebellum Volumes Associated With Neuronal Autoantibodies in Patients With APECED 3.203
Neuroendocrine regulatory peptide-1 and neuroendocrine regulatory peptide-2 influence differentially feeding and penile erection in male rats: sites of action in the brain 3.200
Attività motoria e interazione tra ossitocina, dopamina ed acido glutammico nella Sostanza Nera del ratto maschio: uno studio comportamentale, immunoistochimico e di lesione 3.194
Differential distribution of VGF-derived peptides in the adrenal medulla and evidence for their selective modulation 3.161
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 3.156
Oxytocin induces penile erection when injected into the ventral subiculum: role of nitric oxide and glutamic acid 3.095
Median eminence dopaminergic terminals: a novel auto-immune target in neuro/endocrine disease 2.974
TLQP peptides in amyotrophic lateral sclerosis: possible blood biomarkers with a neuroprotective role 2.946
Novel neuronal and endocrine autoantibody targets in autoimmune polyendocrine syndrome type 1 2.900
A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation 2.898
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.897
VGF peptides as novel biomarkers in Parkinson’s disease 2.824
Targeting Substantia Nigra through Oxytocin Receptors 2.764
null 2.647
Oxytocin injected into the ventral tegmental area induces penile erection and increases extracellular dopamine in the nucleus accumbens and paraventricular nucleus of the hypothalamus of male rats 2.642
Modulation of the VGF derived peptides NERP-1 and –2 upon salt loading and dehydration: novel actors in water homeostasis? 2.587
Oxytocin induces penile erection when injected into the ventral tegmental area of male rats: role of nitric oxide and cyclic GMP 2.477
VGF peptides and peripheral activation of energy expenditure 2.462
Multiple immunofluorescence technology 2.363
VGF metabolic-related gene: distribution of its derived peptides in mammalian pancreatic islets 2.356
TLQP 21 and other Pro-VGF peptides: peripheral and central alternative peptide products from the neuro-endocrine vgf gene and evidence for their modulation. 2.351
The hypothalamic-pituitary axis and autoantibody related disorders 2.322
Alzheimer’s disease related vgf-peptide/s in the mammalian nervous system 2.276
VGF Peptides in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies 2.240
Photoperiodic changes in adiposity increase sensitivity of female Siberian hamsters to systemic VGF derived peptide TLQP-21 2.197
Effect of TLQ-21 peripheral injection on food intake and reproduction mechanisms in female Siberian Hamsters 1.990
Selective VGF-peptide/s changes in human neurodegenerative diseases. 1.973
Novel VGF-derived peptides in homeostatic control: blood and tissue changes of the amidated NERP peptide/s upon salt loading and dehydration 1.951
Peptide products of the neurotrophin-inducible gene vgf are produced in human neuroendocrine cells from early development, and increase in hyperplasia and neoplasia 1.912
BTK inhibitors synergize with 5-FU to treat drug-resistant TP53-null colon cancers 1.894
Dynamic of TLQP-peptides upon fasting 1.852
Analysis of hypothalamic VGF-immunoreactivity in the Siberian Hamster. 1.803
In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat gastric motor functions 1.800
HYPOTHALAMIC-Pituitary axis in aps i: novel autoantibody targets possibly related to endocrine disfunctions 1.751
Pro-VGF-derived peptides induce penile erection in male rats: possible involvement of oxytocin 1.714
Le malattie autoimmuni dell'ipofisi e dell'Ipotalamo 1.494
A role for VGF in the hypothalamic arcuate and paraventricular nuclei in the control of energy homeostasis 1.468
Gastric immunolocalization and plasma profiles of acyl-ghrelin in fasted and fasted-refed prepuberal gilts 1.459
P65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma 1.402
NPY and VGF Immunoreactivity Increased in the Arcuate Nucleus, but Decreased in the Nucleus of the Tractus Solitarius, of Type-II Diabetic Patients 1.374
Tissue cryoarraies: a novel approach to autoantibodies detection 1.302
Tunable, colour coded simultaneus viewing in multiple fluorescence: a novel approach to gene-product espression dynamics. 1.261
Median eminence dopaminergic nerve terminals: a novel target in autoimmune polyendocrine syndrome? 1.237
Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach 1.207
The novel neuroendocrine peptides “nerp-1” and “nerp-2”: changes in altered water balance 1.177
Differential expression and seasonal modulation of VGF peptides in sheep pituitary 1.149
Median eminence dopaminergic terminals: a novel autoimmune target 1.109
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 1.072
Embedding media for cryomicrotomy: an applicative reappraisal 1.032
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity. 1.031
Autoantibodies to anterior pituitary cells and hypothalamic neurons in a girl with type 1 autoimmune polyendocrinopathy (APECED), associated to growth and pubertal retardation 1.019
Autoimmune target within the hypothalamic median eminence in patients with a polyendocrine disease 1.013
VGF-DERIVED PEPTIDES AND THEIR BIOLOGICAL ACTIVITY 949
Equipment testing and tuning: the cold-knife cryomicrotome microm HM-560 884
Autoantibodies targets in the hypothalamic-hypophyseal complex: possibile role in type 1 autoimmune polyendocrinopaty with growth arrest 853
MODULAR MULTI-BAND FLUORESCENCE EXCITATION SYSTEM 824
VGF peptides upon osmotic stimuli: Changes in neuroendocrine regulatory peptides 1 and 2 in the hypothalamic-pituitary-axis and plasma 784
Autoantibodies to anterior pituitary cells and hypothalamic neurons in a girl with type I autoimmune polyendocrinopathy (APECED), associated to growth and pubertal retardation. 702
The "VGF" protein in rat adenohypophysis: sex differences and changes during the estrous cycle and after gonadectomy 600
Simultaneous dual-fluorochromes visualization for co-localization studies 562
Adjustable multi-band excitation and visualization / imaging system for simultaneous viewing multiple fluorescence (DEPOSITO BREVETTO INTERNAZIONALE PCT) 508
Ileal enteroglucagon cells after ileal-duodenal transposition in the rat. 461
Secretin-stimulated trypsin-like immunoreactivity in alcoholics 452
Layer separation of the human bowel for the study of regulatory peptides 436
The endogenous cannabinoid system protects against colonic inflammation 431
Distribution and molecular heterogeneity of galanin in human, pig, guinea pig, and rat gastrointestinal tracts. 426
Presence of PHI in the human intestine 426
ACRYLAMIDE-INDUCED VISCERAL NEUROPATHY: EVIDENCE FOR THE INVOLVEMENT OF CAPSAICIN-SENSITIVE NERVES OF THE RAT URINARY BLADDER 410
Intramural distribution of neuron specific enolase (NSE) in the human gastrointestinal tract. 406
Immunocytochemical evidence for the presence of gamma 1-MSH-like immunoreactivity in pituitary corticotrophs and ACTH-producing tumours. 404
Processing, Distribution and Function of VGF, a Neuronal and Endocrine Peptide Precursor 400
The use of crypt suspensions for endocrine cell quantification. 399
QUANTIFICATION OF ENDOCRINE CELLS IN WHOLE INTESTINAL CRYPTS AND VILLI 388
Immunocytochemistry of serotonin-containing nerves in the human gut. 387
Neuron specific enolase: a common marker for the endocrine cells and innervation of the gut and pancreas. 385
DIRECT EYE VISUALIZATION OF CY5 FLUORESCENCE FOR IMMUNOCYTOCHEMISTRY AND IN SITU HYBRIDIZATION 377
Intramural distribution of regulatory peptides in the sigmoid-recto-anal region of the human gut. 373
Intramural distribution of Met5-enkephalin-Arg6-Gly7-Leu8 in sphincter regions of the human gut. 372
Human distribution and release of a putative new gut hormone, peptide YY. 371
EVIDENCE FOR THE PRESENCE OF S-100 PROTEIN IN THE GLIAL COMPONENT OF THE ENTERIC NERVOUS SYSTEM 371
Mapping, quantitative distribution and origin of substance p- and VIP-containing nerves in the uvea of guinea pig eye. 366
Effect of secretin on serum trypsin-like immunoreactivity in alcoholics 363
Totale 192.135
Categoria #
all - tutte 260.268
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 260.268


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228.446 0 853 427 841 906 576 584 395 868 1.139 1.061 796
2022/202313.015 898 1.703 1.907 1.174 986 1.268 634 985 959 914 1.083 504
2023/202412.635 911 802 637 1.036 1.356 1.717 1.706 865 885 805 945 970
2024/202516.116 2.804 3.852 2.622 1.837 1.106 1.164 1.310 186 307 286 286 356
2025/20269.234 468 368 963 632 603 524 1.529 339 2.443 744 455 166
2026/2027787 548 239 0 0 0 0 0 0 0 0 0 0
Totale 205.919